Cargando…

Harnessing the synergistic potential of biologically targeted therapies in cutaneous T-cell lymphoma

Detalles Bibliográficos
Autores principales:	Patrone, Christina Chung, Geskin, Larisa J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2019
Materias:	News
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6443007/ https://www.ncbi.nlm.nih.gov/pubmed/30956764 http://dx.doi.org/10.18632/oncotarget.26751

Ejemplares similares

Pyoderma gangrenosum in a patient with cutaneous T-cell lymphoma
por: Tang, Randy, et al.
Publicado: (2015)

28665 Cutaneous T-cell lymphoma (CTCL) outcomes during COVID-19
por: Garcia-Saleem, Tiffany J., et al.
Publicado: (2021)

Developing BET-ter treatments for cutaneous T-cell lymphoma
por: Wong, Henry K.
Publicado: (2019)

Dysregulation of the TOX-RUNX3 pathway in cutaneous T-cell lymphoma
por: Dulmage, Brittany O., et al.
Publicado: (2019)

Harnessing the immune system in the treatment of cutaneous T cell lymphomas
por: Fay, Christopher J., et al.
Publicado: (2023)

Stenotrophomonas maltophilia–associated primary cutaneous anaplastic large-cell lymphoma
por: Stonesifer, Connor J., et al.
Publicado: (2021)

Accessibility and readability of online patient education on cutaneous lymphomas
por: Schreidah, Celine M., et al.
Publicado: (2023)

Chlormethine Gel for the Treatment of Skin Lesions in All Stages of Mycosis Fungoides Cutaneous T-Cell Lymphoma: A Narrative Review and International Experience
por: Geskin, Larisa J., et al.
Publicado: (2021)

Harnessing synthetic biology to expand chemical diversity of antibiotics
por: Enam, Fatima
Publicado: (2021)

CD81 as target for B cell lymphomas
por: Küppers, Ralf
Publicado: (2019)

Management of Mycosis Fungoides with Topical Chlormethine/Mechlorethamine Gel: A Columbia University Cutaneous Lymphoma Center Experience
por: GARCIA-SALEEM, Tiffany J., et al.
Publicado: (2021)

The PROVe Study: US Real-World Experience with Chlormethine/Mechlorethamine Gel in Combination with Other Therapies for Patients with Mycosis Fungoides Cutaneous T-Cell Lymphoma
por: Kim, Ellen J., et al.
Publicado: (2021)

Ruxolitinib with resminostat exert synergistic antitumor effects in Cutaneous T-cell Lymphoma
por: Karagianni, Fani, et al.
Publicado: (2021)

United States Cutaneous Lymphoma Consortium recommendations for treatment of cutaneous lymphomas during the COVID-19 pandemic
por: Zic, John A., et al.
Publicado: (2020)

Lupus Erythematosus Tumidus Mimicking Primary Cutaneous Marginal Zone B-cell Lymphoma
por: TRAGER, Megan H., et al.
Publicado: (2020)

Synergistic treatment of TS
por: Gurkar, Aditi U., et al.
Publicado: (2017)

461 A review of cutaneous lymphoma outcomes during COVID-19 pandemic at Columbia University
por: Garcia-Saleem, T., et al.
Publicado: (2021)

Maintenance and Concomitant Therapy Use with Chlormethine Gel Among Patients with Stage IA/IB Mycosis Fungoides-Type Cutaneous T-Cell Lymphoma (MF-CTCL): A Real-World Evidence Study
por: Querfeld, Christiane, et al.
Publicado: (2022)

Update on Biology of Cutaneous T-Cell Lymphoma
por: Phyo, Zaw H., et al.
Publicado: (2020)

International Society for Cutaneous Lymphomas Pandemic Section (ICLYPS) analysis of cutaneous T-cell lymphoma outcomes during the COVID-19 pandemic: A retrospective cohort study
por: Geskin, Larisa J., et al.
Publicado: (2023)

Harnessing the Molecular Fingerprints of B Cell Lymphoma for Precision Therapy
por: Mensah, Afua Adjeiwaa, et al.
Publicado: (2022)

Understanding NK cell biology for harnessing NK cell therapies: targeting cancer and beyond
por: Shin, Eunju, et al.
Publicado: (2023)

The JEM and the JCB : a synergistic partnership
por: Steinman, Ralph M., et al.
Publicado: (2004)

A case of lymphomatoid granulomatosis presenting with cutaneous lesions
por: Shaigany, Sheila, et al.
Publicado: (2015)

BET inhibition in advanced cutaneous T cell lymphoma is synergistically potentiated by BCL2 inhibition or HDAC inhibition
por: Kim, Sa Rang, et al.
Publicado: (2018)

An Update on Molecular Biology of Cutaneous T Cell Lymphoma
por: Walia, Ritika, et al.
Publicado: (2020)

Cell biology beyond the cell
por: Budde, Priya Prakash, et al.
Publicado: (2010)

Reproducibility and cell biology
por: Yamada, Kenneth M., et al.
Publicado: (2015)

Isolated cutaneous Pseudallescheria boydii abscess in an immunocompetent man
por: Stonesifer, Connor J., et al.
Publicado: (2022)

International Cutaneous Lymphomas Pandemic Section (ICLYPS) analysis of CTCL outcomes during COVID-19
por: Geskin, Larisa J, et al.
Publicado: (2021)

Histopathological Markers for Target Therapies in Primary Cutaneous Lymphomas
por: Sonego, Benedetta, et al.
Publicado: (2023)

Biological Approaches to Aggressive Cutaneous B-Cell Lymphomas
por: Tadiotto Cicogna, Giulia, et al.
Publicado: (2019)

The mycosis fungoides cutaneous microenvironment shapes dysfunctional cell trafficking, antitumor immunity, matrix interactions, and angiogenesis
por: Gaydosik, Alyxzandria M., et al.
Publicado: (2023)

Observations by Dr J. Harness, on the Use of the Gastric Fluid of Graminivorous Animals in the Cure of Ulcers
por: Harness, J.
Publicado: (1797)

Fifty years of cell biology
por: Mellman, Ira
Publicado: (2005)

Editorial: Cutaneous T-Cell Lymphomas
por: Chung, Catherine G., et al.
Publicado: (2021)

JAK inhibitors for refractory lymphoma
por: Kimura, Hiroshi
Publicado: (2018)

Harnessing the Potential of Killers and Altruists within the Microbial Community: A Possible Alternative to Antibiotic Therapy?
por: Ikryannikova, Larisa N., et al.
Publicado: (2019)

Amy Kiger: Abuzz on cell biology
por: Sedwick, Caitlin
Publicado: (2008)

The changing world of modern cell biology
por: Misteli, Tom
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_rld0f6a1qhqk8rhfjgfha9n30u